CSIMarket
 
Neuroone Medical Technologies Corporation  (NMTC)
Other Ticker:  
 
 
Price: $1.1600 $0.09 8.411%
Day's High: $1.16 Week Perf: 5.45 %
Day's Low: $ 1.07 30 Day Perf: -7.94 %
Volume (M): 96 52 Wk High: $ 2.07
Volume (M$): $ 112 52 Wk Avg: $1.28
Open: $1.10 52 Wk Low: $0.85



 Market Capitalization (Millions $) 28
 Shares Outstanding (Millions) 24
 Employees -
 Revenues (TTM) (Millions $) 3
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) 0

Neuroone Medical Technologies Corporation
Each day, there are more and more city cafes, malls and entertainment centers with food courts, private products and meal delivery companies, open air cafes, and automated snacks and drinks machines.

This has given us the idea to produce a product that would not only be interesting, but essential, as the demand for high quality paper cups is significantly high.

We want to produce disposable paper cups that will be bright and funny with printed cartoons, graphics, etc., of different sizes, so that they are memorable, high-quality and affordable.

Disposable paper tableware combines usability, availability and ecological safety. Its advantages have made this product very popular. Many large companies in the food industry have successfully used this product for safe and convenient packing. The paper tableware application area is not limited to only selling foods and drinks. It is also widely used for brand awareness, as well as the promotion of products and services as an effective advertising vehicle. We can find paper cups in many places – fast food restaurants and cafes, movie theaters and restaurants and in many other public places.

The primary advantage of paper cups is their non-toxicity, utilization simplicity and environmental safety.

We have purchased a fully-automatic portable paper cup forming machine which doesn’t require high technical skills to complete the product manufacturing process. The machine delivery set includes all necessary equipment and primary products for machine installation and testing.



   Company Address: 7599 Anagram Drive Eden Prairie 55344 MN
   Company Phone Number: 426-1383   Stock Exchange / Ticker: NASDAQ NMTC
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Neuroone Medical Technologies Corporation

Neuroone Medical Technologies Corporation Sees Massive Revenue Growth but Struggles to Turn Profit 2.

Neuroone Medical Technologies Corporation has reported impressive revenue growth of 753.253% year on year, reaching $0.98 million in the fiscal period ending December 31, 2023. This is a significant increase compared to the medical equipment and supplies industry average of 4.08% during the same time frame. Despite this strong revenue growth, the company also saw an increase in deficit per share, reaching $-0.14.
While the company did experience a higher deficit compared to the previous reporting period, with a net deficit of $-3.345 million, it is important to note that this may be due to the seasonal nature of the business. Additionally, Neuroone Medical Technologies Corporation has managed to decrease its inventories to $1.6 million from the previous quarter, although this marks an increase compared to the same period a year ago.

Neuroone Medical Technologies Corporation

Neuroone Medical Technologies Corporation's Record-Breaking Surge in Revenue Turns Bittersweet as Break-Even Remains Elusive in Q4 2023

Neuroone Medical Technologies Corporation has made waves in the Medical Equipment & Supplies industry with its impressive financial results for the fourth quarter of 2023 earnings season. The company reported a remarkable revenue advance of 978.357% year on year, reaching $0.74 million. However, it is important to note that this impressive growth is accompanied by some concerning figures.
The company's earnings per share (EPS) for the quarter stood at $-0.13, indicating diminishing returns. While Neuroone Medical Technologies Corporation outperformed its industry peers, who only achieved a 5.26% revenue advance during the same period, the negative EPS is a point of concern.

Neuroone Medical Technologies Corporation

Neuroone Medical Technologies Corp Achieves Remarkable 1865% Revenue Surge in Q3 2023, Battles Back from Recent Stocks Dip

During the past week, Neuroone Medical Technologies Corp stock experienced a decline of -5.26%. This decrease brings the year to date performance down to -25%. However, despite this recent drop, the stock is still trading at a 35% higher value than its 52 week low.
One of the factors that may have contributed to the decline in Neuroone Medical Technologies Corp stock is the announcement of their financial results for the third quarter of 2023. While the company reported a significant revenue growth of 1865.447% year on year, reaching $0.63 million, their deficit also extended to $-0.20. This deficit may have caused concern among investors and led to a decrease in the stock's value.

Neuroone Medical Technologies Corp

Neuroone Medical Technologies Corp Faces Financial Struggles with Cumulative Net Loss of $-9 Million and Negative Return on Equity of -110.7%

Neuroone Medical Technologies Corp has not been performing well financially, as evident from its recent results. The company recorded a cumulative net loss of $-9 million during the 12 months ending in the second quarter of 2023, leading to a negative return on equity (ROE) of -110.7%. This indicates that the company is not generating profits and its investors are not obtaining any returns on their investments.
Moreover, within the Medical Equipment & Supplies industry, 94 other companies had a higher return on equity. This means that the competitors of Neuroone Medical Technologies Corp are performing better than it is and are likely attracting more investors.
Although Neuroone Medical Technologies Corp reported a very robust revenue rise of 1174.262% year on year, reaching $0.47 million in the most recent fiscal period, it also increased its loss per share to $-0.21, compared to a loss of $-0.11 per share in the previous financial reporting period. This is a worrying trend, indicating that the company is incurring increasing expenses while generating little revenue.
Furthermore, for the fiscal interval ending March 31, 2023, Neuroone Medical Technologies Corp realized a net loss of $-3.523 million, which is larger than the $-3.058 million loss it recorded in the previous year. This suggests that the company has not been able to improve its financial performance, despite its efforts.






 

Neuroone Medical Technologies's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com